Search

everythinglearnresearchcommunity

for

Search:↓

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Male pattern baldness may predict prostate cancer risk.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Finasteride treats hair loss and reduces prostate cancer risk.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.